EUVIMEDEUVIMED entdecken
Crossref

3D-bioprinted osteochondral model based on hierarchical polymeric microarchitectures for in vitro osteoarthritis drug screening

Yi-Cheng Wang, Xiao-Jie Song, Xiao-Chang Lu, Zhou-Jiang Chen, Yue-Wei Li, Ranjith Kumar Kankala, Ai-Zheng Chen, Shi-Bin Wang, Chao-Ping Fu

International Journal of Bioprinting · 10.09.2025 · 11 (6) · 220

DOI: 10.36922/ijb025290288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Bioprinting, online erschienen am 10.09.2025. Verfasst von Yi-Cheng Wang und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compared to conventional two-dimensional (2D) or scaffold-free three-dimensional (3D) drug screening models, biomimetic osteochondral constructs offer superior physiological relevance for studying osteoarthritis (OA) and accelerating therapeutic discovery. This study reports the development of a polymeric microarchitecture (PM)- based 3D osteochondral model for drug screening applications. Microfluidics-assisted fabrication enabled the generation of cartilage-like and osteogenic microtissues by encapsulating chondrocytes and endothelial/osteoblast cells within PMs. These multicellular aggregates were embedded in gelatin methacryloyl and assembled via 3D bioprinting into a stratified osteochondral construct. The model exhibited favorable cell viability, high proliferation, and organized microtissue formation, validating its biological functionality. An OA-like microenvironment was induced using lipopolysaccharide, significantly elevating pro-inflammatory cytokines. Treatment with diclofenac, dexamethasone, or curcumin markedly attenuated this response, reducing tumor necrosis factor-alpha, interleukin (IL)-1β, and IL-6 to 42.1, 193.5, and 193.5 pg/mL, respectively, while elevating the anti-inflammatory cytokine IL-10 to 90.2 pg/mL. Overall, this PM-based 3D osteochondral platform reproduces key features of native joint tissue and holds promise for OA research, drug screening, and regenerative medicine.  

Zitieren

APA

Wang, Y., Song, X., Lu, X., Chen, Z., Li, Y., Kankala, R. K., Chen, A., Wang, S., & Fu, C. (2025). 3D-bioprinted osteochondral model based on hierarchical polymeric microarchitectures for in vitro osteoarthritis drug screening. International Journal of Bioprinting, 11(6), 220. https://doi.org/10.36922/ijb025290288

Vancouver

Wang Y, Song X, Lu X, Chen Z, Li Y, Kankala RK, et al. 3D-bioprinted osteochondral model based on hierarchical polymeric microarchitectures for in vitro osteoarthritis drug screening. International Journal of Bioprinting. 2025;11(6):220. doi:10.36922/ijb025290288

BibTeX
@article{Wang2025,
  author = {Wang, Yi-Cheng and Song, Xiao-Jie and Lu, Xiao-Chang and Chen, Zhou-Jiang and Li, Yue-Wei and Kankala, Ranjith Kumar and Chen, Ai-Zheng and Wang, Shi-Bin and Fu, Chao-Ping},
  title = {3D-bioprinted osteochondral model based on hierarchical polymeric microarchitectures for in vitro osteoarthritis drug screening},
  journal = {International Journal of Bioprinting},
  year = {2025},
  volume = {11},
  number = {6},
  pages = {220},
  doi = {10.36922/ijb025290288}
}
Kostenlos starten →